Business Context and Reporting Period
This Form 8-K reports on the results of the 2021 Annual Meeting of Stockholders held by MyMD Pharmaceuticals, Inc. on December 29, 2021. The company is incorporated in New Jersey and its common stock trades on The Nasdaq Capital Market under the symbol MYMD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
At the Annual Meeting, 31,371,678 votes were present in person or by proxy. The following matters were voted upon:
- Election of Directors: All six nominees were elected to serve for a term expiring at the 2022 annual meeting.
- Chris Chapman: 26,548,186 For; 58,587 Withheld.
- Craig Eagle: 26,599,709 For; 7,064 Withheld.
- Christopher C. Schreiber: 26,557,751 For; 49,022 Withheld.
- Joshua Silverman: 24,859,416 For; 1,747,357 Withheld.
- Jude Uzonwanne: 26,597,722 For; 9,051 Withheld.
- Bill J. White: 26,138,800 For; 467,973 Withheld.
- Ratification of Auditors: The appointment of Morison Cogen LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified.
- Votes For: 31,345,919
- Votes Against: 22,163
- Votes Abstaining: 3,596
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document states that no other matters were considered or voted upon at the meeting.
Important Facts for Investors to Verify
- Verify the full text of the definitive proxy statement filed on November 22, 2021, for detailed background on the director nominees and auditor ratification.
- Note the significant number of broker non-votes (4,764,905) recorded for the election of directors.
- Confirm the specific term expiration dates for the newly elected directors, which are set for the 2022 annual meeting.